NCT00523354View on ClinicalTrials.gov

Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

October 31, 2007

Conditions
Esophagitis
Interventions
DRUG

Infliximab

Induction therapy with 2 infusions, each 5 mg/kg body weight within 2 wks

Trial Locations (1)

4600

EE-Clinics, Praxis Roemerhof, Olten

All Listed Sponsors
lead

Swiss EE Study Group

OTHER

NCT00523354 - Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis | Biotech Hunter | Biotech Hunter